Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chloroxine |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylbenzethonium |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Merbromin |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bismuth violet |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Boric acid topical agent |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorothymol |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylbenzethonium chloride |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal zinc peroxide |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine solution |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorhydroxyquinoline |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mercuric iodide |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitromersol |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triclobisonium chloride (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal iodine |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Yellow mercuric oxide yellow |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ammoniated mercury |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminoacridine (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mafenide (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxychlorosene (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzethonium (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Silver nitrate (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzalkonium (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Skin anti-infective (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetylpyridinium chloride 0.066% lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetylpyridinium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium perborate 68.6% mouthwash (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Silver sulfadiazine 10mg/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Povidone iodine |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triclosan (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hexachlorophene |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ichthammol (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Domiphen (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mupirocin |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium perborate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mercury ammonium chloride (substance) |
Is a |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate 0.5% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin+hydrocortisone 0.5%/1.5% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracycline hydrochloride 2.2 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin 0.5% cream BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Compound neomycin preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely framycetin sulfate 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing neomycin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical neomycin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical tetracycline (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulfate+trimethoprim eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulfate+bacitracin zinc eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulfate+trimethoprim eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing framycetin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Skin antibiotic (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulf [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulf [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin ear ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin 0.5% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone/neomycin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate 25 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracycline hydrochloride 1%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracycline hydrochloride 1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin b sulfate 100% powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/3.5gm/10000unt ointment (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin zinc + polymyxin b sulphate 500unt/10000unt ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Colistin sulfate + hydrocortisone acetate + neomycin sulfate 0ns/10mg/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone + neomycin sulphate 1mg/3.5mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone sodium phospha + neomycin sulphate 0ns/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gramicidin + neomycin sulfate + polymyxin b sulphate 0.025mg/1.75mg/10000unt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anti-infectieux cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|